Identifying beneficial gastric cancer patient on prognosis after treating with perioperative or postoperative-only chemotherapy: a single-center real-world study

Identifying beneficial gastric cancer patient on prognosis after treating with perioperative or postoperative-only chemotherapy: a single-center real-world study

Abstract Background This study evaluates the impact of perioperative S-1 and oxaliplatin (SOX) versus postoperative SOX or capecitabine and oxaliplatin (XELOX) on patient prognosis to identify suitable candidates for each therapy. Method A retrospective real-world cohort study was conducted using da...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiwei Zhu, Jiaqing Zhang, Siwei Pan, Ruolan Zhang, Yanqiang Zhang, Qing Yang, Can Hu, Zhiyuan Xu
Format: Article
Language:English
Published: BMC 2025-05-01
Series:World Journal of Surgical Oncology
Subjects:
Gastric cancer
Real-world study
Propensity score matching
Neoadjuvant therapy
Online Access:https://doi.org/10.1186/s12957-025-03827-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12957-025-03827-w

Similar Items